Skip to main navigation Skip to search Skip to main content

IPF biomarker assay development for RX0007 target engagement in IPF/ILD patients

Project Details

StatusFinished
Effective start/end date1/07/2228/02/23

Funding

  • RedX Pharma Plc: £73,905.00